What is Ovid Therapeutics Inc. Common Stock's Market Cap?

Ovid Therapeutics Inc. Common Stock's Market Cap is $537.1M, based on as-reported figures from SEC (XBRL) filings.

What is Ovid Therapeutics Inc. Common Stock's Enterprise Value?

Ovid Therapeutics Inc. Common Stock's Enterprise Value is $525.7M, based on as-reported figures from SEC (XBRL) filings.

What is Ovid Therapeutics Inc. Common Stock's Price / Sales?

Ovid Therapeutics Inc. Common Stock's Price / Sales is 339.3×, based on as-reported figures from SEC (XBRL) filings.

What is Ovid Therapeutics Inc. Common Stock's EV / Revenue?

Ovid Therapeutics Inc. Common Stock's EV / Revenue is 332.1×, based on as-reported figures from SEC (XBRL) filings.

What is Ovid Therapeutics Inc. Common Stock's EV / EBITDA?

Ovid Therapeutics Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Ovid Therapeutics Inc. Common Stock's Revenue (TTM)?

Ovid Therapeutics Inc. Common Stock's Revenue (TTM) is $1.6M, based on as-reported figures from SEC (XBRL) filings.

What is Ovid Therapeutics Inc. Common Stock's Net Income (TTM)?

Ovid Therapeutics Inc. Common Stock's Net Income (TTM) is -$34.5M, based on as-reported figures from SEC (XBRL) filings.

What is Ovid Therapeutics Inc. Common Stock's EBITDA?

Ovid Therapeutics Inc. Common Stock's EBITDA is -$58.3M, based on as-reported figures from SEC (XBRL) filings.

What is Ovid Therapeutics Inc. Common Stock's Diluted EPS (TTM)?

Ovid Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -0.18, based on as-reported figures from SEC (XBRL) filings.

What is Ovid Therapeutics Inc. Common Stock's EBITDA Margin?

Ovid Therapeutics Inc. Common Stock's EBITDA Margin is -3681.2%, based on as-reported figures from SEC (XBRL) filings.

Ovid Therapeutics Inc. Common Stock (OVID) Financial Statements

Ovid Therapeutics Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG009F0TD85

XNAS · usd

2.75▼ 0.05 (-1.79%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close2.80

Day's Range2.73 – 2.81

52-Week Range1.12 – 3.11

Volume1.1M

Avg Volume1.4M

Share Statistics

Shares Outstanding

Employees23

ExchangeXNAS

Listed2017-05-05

Share count as of August 11, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Ovid Therapeutics Inc. Common Stock (OVID)

What is Ovid Therapeutics Inc. Common Stock's Market Cap?: Ovid Therapeutics Inc. Common Stock's Market Cap is $537.1M, based on as-reported figures from SEC (XBRL) filings.
What is Ovid Therapeutics Inc. Common Stock's Enterprise Value?: Ovid Therapeutics Inc. Common Stock's Enterprise Value is $525.7M, based on as-reported figures from SEC (XBRL) filings.
What is Ovid Therapeutics Inc. Common Stock's Price / Sales?: Ovid Therapeutics Inc. Common Stock's Price / Sales is 339.3×, based on as-reported figures from SEC (XBRL) filings.
What is Ovid Therapeutics Inc. Common Stock's EV / Revenue?: Ovid Therapeutics Inc. Common Stock's EV / Revenue is 332.1×, based on as-reported figures from SEC (XBRL) filings.
What is Ovid Therapeutics Inc. Common Stock's EV / EBITDA?: Ovid Therapeutics Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Ovid Therapeutics Inc. Common Stock's Revenue (TTM)?: Ovid Therapeutics Inc. Common Stock's Revenue (TTM) is $1.6M, based on as-reported figures from SEC (XBRL) filings.
What is Ovid Therapeutics Inc. Common Stock's Net Income (TTM)?: Ovid Therapeutics Inc. Common Stock's Net Income (TTM) is -$34.5M, based on as-reported figures from SEC (XBRL) filings.
What is Ovid Therapeutics Inc. Common Stock's EBITDA?: Ovid Therapeutics Inc. Common Stock's EBITDA is -$58.3M, based on as-reported figures from SEC (XBRL) filings.
What is Ovid Therapeutics Inc. Common Stock's Diluted EPS (TTM)?: Ovid Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -0.18, based on as-reported figures from SEC (XBRL) filings.
What is Ovid Therapeutics Inc. Common Stock's EBITDA Margin?: Ovid Therapeutics Inc. Common Stock's EBITDA Margin is -3681.2%, based on as-reported figures from SEC (XBRL) filings.